Risk-reducing total gastrectomy in asymptomatic CDH1 carriers
ConclusionRisk-reducing total gastrectomy remains the best clinical management for patients with hereditary diffuse gastric cancer harboring a germline, pathogenicCDH1 variant. In our series, intramucosal carcinoma foci were found in the great majority (89.5%) ofCDH1 carriers.
Source: European Surgery - Category: Surgery Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Endoscopy | Gastrectomy | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Laparoscopy | Study | Surgery | Weight Loss